Challenges of PK/PD measurements in modern drug development

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Oncogene·2020

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Blood cancer journal·2017

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Psychological medicine·2016

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Oncogene·2013

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

British journal of cancer·2013

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

Clinical pharmacology and therapeutics·2013

Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?

European journal of cancer (Oxford, England : 1990)·2026

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.

European journal of cancer (Oxford, England : 1990)·2026

Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.

European journal of cancer (Oxford, England : 1990)·2026

Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.

European journal of cancer (Oxford, England : 1990)·2026

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

European journal of cancer (Oxford, England : 1990)·2026

Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.

European journal of cancer (Oxford, England : 1990)·2026

Virtual screening of human pancreatic lipase inhibitors using an integrated transfer learning and molecular dynamics simulation.

Bioinformation·2026

The Evolution of Medications for Obesity Management.

JGH open : an open access journal of gastroenterology and hepatology·2026

Elucidating the release and permeation mechanisms of emulsion-type cataplasms from a structural perspective.

International journal of pharmaceutics·2026

Dapagliflozin as an adjunct to insulin improves glycemic control, weight, and lipid profile with a superior safety profile in type 2 diabetes: a randomized trial.

Clinics (Sao Paulo, Brazil)·2026

Standardizing pre-existing anti-PEG antibody detection: A key to clarifying their binding features and clinical relevance.

Journal of pharmaceutical analysis·2026

Pharmacist-led medication therapy management improving medication adherence in a patient with type 2 diabetes: case report.

Frontiers in medicine·2026

Related Experiment Videos

Challenges of PK/PD measurements in modern drug development

Related Concept Videos

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.

Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.

Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.

Virtual screening of human pancreatic lipase inhibitors using an integrated transfer learning and molecular dynamics simulation.

The Evolution of Medications for Obesity Management.

Elucidating the release and permeation mechanisms of emulsion-type cataplasms from a structural perspective.

Dapagliflozin as an adjunct to insulin improves glycemic control, weight, and lipid profile with a superior safety profile in type 2 diabetes: a randomized trial.

Standardizing pre-existing anti-PEG antibody detection: A key to clarifying their binding features and clinical relevance.

Pharmacist-led medication therapy management improving medication adherence in a patient with type 2 diabetes: case report.

Related Experiment Videos

Challenges of PK/PD measurements in modern drug development

Related Concept Videos

Related Articles